Sri Mosur, CEO,
President Global Drug Discovery & Development.
Sri(dhar)
Mosur, President and CEO of Jubilant Discovery Services
Inc, and Jubilant Biosys Ltd., India, a subsidiary of the
jubilant group of companies, has been involved in
developing research and manufacturing alliances between
India China and the global pharmaceutical Industry for
over 19 years. Having extensive hands on experience of the
emerging markets, Sri has a very good perspective of the
capabilities in the emerging markets of India and China
and the needs of the global pharmaceutical industry.
His expertise includes developing integrated and
functional alliances in collaborative research and
development alliances. Having worked with major
pharmaceutical, biotech and venture funding companies in
the last two decades, Sri brings a very good perspective
of the needs, capabilities and the potential synergies
between the mature and emerging markets. Sri has directed,
strategically and functionally, multiple pioneering
alliances between these two markets since 1995.
Sri's past and current obligations include: Stint with
Indian Pharmaceutical industry, early in his career,
Partner in Austin Chemical Company Inc, a Chicago based
company involved in outsourcing alliances for major pharma,
Strategic consulting to a large mid-western pharma in
setting up their research and development strategy in
India, the board of Pharma Innovation LLc, a biotech
offshoot from Columbia university. NY, Board of Muroplex
Inc.
At Jubilant, reporting to the Board, Sri is responsible
for leading collaborative research and development
vertical with Jubilant.
Over the last decade, Sri has been involved quite
extensively in promoting alliances within the industry, to
include multiple speaking assignments in global forums to
include: NAPM, DCAT, SOCMA-Informex, ISM, Harvard
Business School, Wharton Business School, Bio, and
multiple other industry and government forums.
Sri is a Chemical engineer and apart from developing
successful business models, Sri also has extensive
functional experience in global regulatory compliance,
project management and chemical process development.
